Country: Malaysia
Bahasa: Inggeris
Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
EZETIMIBE
ACCORD HEALTHCARE SDN.BHD.
EZETIMIBE
30tablet Tablets; 10tablet Tablets
INTAS PHARMACEUTICALS LIMITED
_Consumer Medication Information Leaflet (RiMUP) _ ACCORD EZETIMIBE 10 Ezetimibe Tablets 10 mg Page 1 of 3 WHAT IS IN THIS LEAFLET? 1. What ACCORD EZETIMIBE is used for 2. How ACCORD EZETIMIBE works 3. Before you use ACCORD EZETIMIBE 4. How to take ACCORD EZETIMIBE 5. While you are using ACCORD EZETIMIBE 6. Side effects 7. Storage and disposal of ACCORD EZETIMIBE 8. Product description 9. Manufacturer and Product Registration Holder 10. Date of Revision WHAT ACCORD EZETIMIBE IS USED FOR ACCORD EZETIMIBE is a tablet that contains mg of ezetimibe as the active ingredient. • ACCORD EZETIMIBE is a cholesterol-lowering medicine. • ACCORD EZETIMIBE is for patients whose cholesterol levels are too high and when diet alone cannot lower these levels adequately. • ACCORD EZETIMIBE reduces elevated total- cholesterol, LDL (bad) cholesterol and triglycerides and increases HDL (good) cholesterol. • ACCORD EZETIMIBE may be taken with other cholesterol-lowering medicines known as statins or alone, in addition to diet. • ACCORD EZETIMIBE may be taken with fenofibrate, another cholesterol-lowering medicine, in addition to diet. If you have sitosterolemia, your doctor has prescribed ACCORD EZETIMIBE to lower the level of plant sterols in your blood. Sitosterolemia is a hereditary illness that increases the levels of plant sterols in your blood. HOW ACCORD EZETIMIBE WORKS • ACCORD EZETIMIBE works by decreasing the absorption of cholesterol in the small intestine. Statins and fenofibrate lower cholesterol in a different way; they work in the liver. • ACCORD EZETIMIBE adds to the cholesterol-lowering effect of statins and fenofibrate. WHY HAS MY DOCTOR PRESCRIBED ACCORD EZETIMIBE? Your doctor has prescribed ACCORD EZETIMIBE to reduce the amount of cholesterol and triglycerides in your blood. Cholesterol is one of several fatty substances found in the bloodstream. Your total cholesterol is made up mainly of LDL and HDL cholesterol. LDL cholesterol is often called “bad” cholesterol because it can build up in the walls Baca dokumen lengkap
ACCORD EZETIMIBE 10 (Ezetimibe Tablets 10 mg) ● NAME AND STRENGTH OF ACTIVE INGREDIENT Ezetimibe 10 mg ● PRODUCT DESCRIPTION ACCORD EZETIMIBE 10: White to off white, capsule shaped, flat faced with beveled edge, uncoated tablets, debossed with “10” on one side and plain on other side. ● PHARMACODYNAMICS & PHARMACOKINETICS _PHARMACODYNAMIC PROPERTIES_ Pharmacotherapeutic group: Other lipid modifying agents, ATC code: C10A X09 _MECHANISM OF ACTION: _Ezetimibe is in a new class of lipid-lowering compounds that selectively inhibit the intestinal absorption of cholesterol and related plant sterols. Ezetimibe is orally active, and has a mechanism of action that differs from other classes of cholesterol-reducing compounds (e.g. statins, bile acid sequestrants [resins], fibric acid derivatives, and plant stanols). The molecular target of ezetimibe is the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is responsible for the intestinal uptake of cholesterol and phytosterols. Ezetimibe localises at the brush border of the small intestine and inhibits the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver; statins reduce cholesterol synthesis in the liver and together these distinct mechanisms provide complementary cholesterol reduction. In a 2-week clinical study in 18 hypercholesterolaemic patients, Ezetimibe inhibited intestinal cholesterol absorption by 54%, compared with placebo. Ezetimibe inhibited the absorption of [ 14 C]-cholesterol with no effect on the absorption of triglycerides, fatty acids, bile acids, progesterone, ethinyl estradiol, or fat soluble vitamins A and D. Epidemiologic studies have established that cardiovascular morbidity and mortality vary directly with the level of total-C and LDL-C and inversely with the level of HDL-C. A beneficial effect of Ezetimibe on cardiovascular morbidity and mortality has not yet been demonstrated. _PHARMACOKINETIC PROPERTIES_ _ABSORPTION: _After oral administration, ezetimibe is rapidly absorbed Baca dokumen lengkap